STOCK TITAN

Amarin Financials

AMRN
FY2025 annual
Revenue $213.6M -6.5% YoY
Net Income -$38.8M +55.4% YoY
EPS (Diluted) -$0.09 +55.0% YoY
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Amarin (AMRN) reported $213.6M in revenue for fiscal year 2025, down 6.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMRN FY2025

Margin repair and a smaller commercial cost base are reducing cash burn faster than sales are stabilizing.

In FY2025, the company still posted a net loss of -$38.8M, yet operating cash flow turned positive at $6.7M. Because revenue continued to slip while gross margin rebounded from 35.6% to 56.6%, the improvement looks driven more by margin repair and cost reset than by renewed volume, a sign that accounting losses now overstate the immediate cash drain.

The core operating challenge is scale: FY2025 gross profit was $120.9M, while SG&A alone consumed $115.0M. After adding R&D, the business still could not cover its operating platform, which means the recent narrowing of losses reflects a leaner structure rather than a fully self-funding model; efficiency is improving, but economic scale has not been rebuilt.

The balance sheet is cushioning the transition, with cash at $134.7M and a current ratio of 3.3x in FY2025. Liabilities of $211.5M remained well below equity of $459.3M, so near-term pressure comes more from sustaining operations and managing working capital than from debt service, which matters while sales are still shrinking.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 33 / 100
Financial Health Score 33/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Amarin's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
25

Amarin has an operating margin of -23.5%, meaning the company loses $23 on every $100 of revenue. This results in a profitability score of 25/100. This is up from -40.2% the prior year.

Growth
6

Amarin's revenue declined 6.5% year-over-year, from $228.6M to $213.6M. This contraction results in a growth score of 6/100.

Leverage
61

Amarin has a moderate D/E ratio of 0.46. This balance of debt and equity financing earns a leverage score of 61/100.

Liquidity
81

With a current ratio of 3.34, Amarin holds $3.34 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 81/100.

Cash Flow
0

Not available for Amarin, and counted as zero in the overall score.

Returns
27

Amarin posts a -8.5% return on equity (ROE), meaning it loses $8 for every $100 of shareholders' equity. This results in a returns score of 27/100. This is up from -17.9% the prior year.

Altman Z-Score Distress
-1.85

Amarin scores -1.85, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($292.3M) relative to total liabilities ($211.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

Amarin passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

Amarin reported a net loss of $38.8M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Amarin reported an operating loss of $50.2M against $7K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$213.6M
YoY-6.5%
5Y CAGR-19.0%
10Y CAGR+10.1%

Amarin generated $213.6M in revenue in fiscal year 2025. This represents a decrease of 6.5% from the prior year.

Net Income
-$38.8M
YoY+55.4%

Amarin reported -$38.8M in net income in fiscal year 2025. This represents an increase of 55.4% from the prior year.

EPS (Diluted)
-$0.09
YoY+55.0%

Amarin earned -$0.09 per diluted share (EPS) in fiscal year 2025. This represents an increase of 55.0% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt
$134.7M
YoY+11.3%
5Y CAGR-6.4%
10Y CAGR+2.3%

Amarin held $134.7M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
416M
YoY+1.1%
5Y CAGR+1.2%

Amarin had 416M shares outstanding in fiscal year 2025. This represents an increase of 1.1% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
56.6%
YoY+21.0pp
5Y CAGR-22.0pp
10Y CAGR-9.3pp

Amarin's gross margin was 56.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 21.0 percentage points from the prior year.

Operating Margin
-23.5%
YoY+16.7pp
5Y CAGR-20.3pp

Amarin's operating margin was -23.5% in fiscal year 2025, reflecting core business profitability. This is up 16.7 percentage points from the prior year.

Net Margin
-18.2%
YoY+19.9pp
5Y CAGR-15.2pp

Amarin's net profit margin was -18.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 19.9 percentage points from the prior year.

Return on Equity
-8.5%
YoY+9.4pp
5Y CAGR-5.6pp

Amarin's ROE was -8.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 9.4 percentage points from the prior year.

Capital Allocation

R&D Spending
$19.8M
YoY-5.1%
5Y CAGR-12.7%
10Y CAGR-9.0%

Amarin invested $19.8M in research and development in fiscal year 2025. This represents a decrease of 5.1% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

AMRN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AMRN annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$186.2M$213.6M-6.5%$228.6M-25.5%$306.9M-16.9%$369.2M-36.7%$583.2M-5.0%$614.1M+42.9%$429.8M+87.5%$229.2M+26.6%$181.1M+39.2%$130.1M+59.1%$81.8M+50.8%$54.2M+105.7%$26.4MN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A$121.3M-7.7%$131.4M+36.9%$96.0M+76.0%$54.5M+21.3%$45.0M+30.8%$34.4M+23.3%$27.9M+36.1%$20.5M+72.0%$11.9MN/AN/A
Gross Profit$78.1M$120.9M+48.5%$81.4M-50.8%$165.5M-31.7%$242.5M-47.5%$461.9M-4.3%$482.6M+44.6%$333.7M+91.1%$174.7M+28.3%$136.2M+42.2%$95.7M+77.7%$53.9M+59.8%$33.7M+133.5%$14.4MN/AN/A
R&D Expenses$19.0M$19.8M-5.1%$20.9M-6.1%$22.2M-26.9%$30.4M+3.8%$29.3M-24.8%$39.0M+13.3%$34.4M-38.5%$55.9M+18.5%$47.2M-5.6%$50.0M-2.1%$51.1M+1.5%$50.3M-30.8%$72.8M+23.4%$59.0M+172.9%$21.6M
SG&A Expenses$83.1M$115.0M-24.5%$152.3M-23.8%$199.9M-34.3%$304.4M-25.4%$408.3M-11.9%$463.3M+43.2%$323.6M+42.6%$227.0M+68.7%$134.5M+20.8%$111.4M+10.2%$101.0M+27.3%$79.3M-35.9%$123.8M+114.2%$57.8M+156.2%$22.6M
Operating Income-$40.8M-$50.2M+45.3%-$91.8M-35.8%-$67.6M+36.2%-$105.9M-1108.1%$10.5M+153.4%-$19.7M+19.0%-$24.3M+77.6%-$108.2M-137.6%-$45.6M+30.6%-$65.6M+33.2%-$98.2M-2.4%-$96.0M+47.3%-$182.1M-56.0%-$116.8M-164.4%-$44.2M
Interest ExpenseN/A$7K0.0%$7K-12.5%$8K-46.7%$15K-88.4%$129K-95.0%$2.6M-60.7%$6.6M-25.3%$8.9M-9.2%$9.8M-47.7%$18.7M-7.4%$20.2M+8.6%$18.6M-45.7%$34.2M+88.9%$18.1M+1809000.0%$1K
Income Tax$1.6M$2.8M-44.8%$5.0M-8.4%$5.4M+172.4%$2.0M-43.9%$3.6M+378.1%$745K+354.3%$164K+70.8%$96K-99.3%$13.0M+30.9%$10.0M+423.0%-$3.1M-8.8%-$2.8M+11.2%-$3.2M-135.0%$9.1M+262.3%$2.5M
Net Income-$27.1M-$38.8M+55.4%-$87.0M-58.2%-$55.0M+48.0%-$105.8M-1474.0%$7.7M+142.8%-$18.0M+20.5%-$22.6M+80.6%-$116.4M-71.6%-$67.9M+21.4%-$86.3M+25.0%-$115.2M-104.4%-$56.4M+66.1%-$166.2M+7.2%-$179.2M-159.2%-$69.1M
EPS (Diluted)-$0.09+55.0%-$0.20-33.3%-$0.15+42.3%-$0.26-1400.0%$0.02+140.0%-$0.05+28.6%-$0.07+82.1%-$0.39-56.0%-$0.25+39.0%-$0.41-$0.83-130.6%-$0.36+71.9%-$1.28-3.2%-$1.24-134.0%-$0.53

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

AMRN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AMRN annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$670.8M-2.1%$685.3M-17.6%$831.7M-6.1%$886.2M-17.0%$1.1B+10.6%$966.0M+9.5%$882.2M+128.7%$385.7M+138.7%$161.6M-3.2%$167.0M-3.6%$173.2M+1.2%$171.1M-32.2%$252.5M-18.8%$310.9M+146.0%$126.4M
Current Assets$649.9M+9.2%$595.4M-17.9%$725.0M+5.2%$689.1M-21.6%$878.7M-0.1%$879.2M+2.8%$855.0M+126.2%$378.0M+146.6%$153.3M+4.7%$146.3M+2.0%$143.5M-1.2%$145.3M-33.8%$219.4M-23.2%$285.7M+140.1%$119.0M
Cash & Equivalents$134.7M+11.3%$121.0M-39.3%$199.3M-8.5%$217.7M-0.8%$219.5M+17.4%$187.0M-71.0%$644.6M+158.6%$249.2M+238.5%$73.6M-25.1%$98.3M-8.1%$107.0M-10.5%$119.5M-37.6%$191.5M-26.4%$260.2M+123.2%$116.6M
Inventory$195.9M+18.0%$166.0M-35.8%$258.6M+13.1%$228.7M-2.5%$234.7M+24.3%$188.9M+146.0%$76.8M+32.8%$57.8M+91.0%$30.3M+47.6%$20.5M+8.0%$19.0M+38.2%$13.7M-35.2%$21.2M-0.2%$21.3MN/A
Accounts Receivable$126.8M+3.7%$122.3M-8.4%$133.6M+2.0%$131.0M-20.0%$163.7M+5.9%$154.6M+32.8%$116.4M+75.0%$66.5M+46.8%$45.3M+126.8%$20.0M+44.5%$13.8M+76.3%$7.8M+115.1%$3.6MN/AN/A
Total Liabilities$211.5M+6.2%$199.2M-28.8%$279.6M-3.9%$290.8M-27.5%$401.0M+18.4%$338.5M+23.6%$273.9M+17.4%$233.4M+2.9%$226.7M+28.8%$176.1M-41.5%$300.8M+15.9%$259.6M-9.4%$286.3M-9.1%$314.9M+137.9%$132.3M
Current Liabilities$194.5M+8.1%$179.9M-30.6%$259.3M-0.1%$259.5M-30.0%$370.7M+20.6%$307.4M+26.9%$242.2M+54.0%$157.3M+44.9%$108.5M+42.3%$76.2M+50.3%$50.7M+25.8%$40.3M+7.4%$37.5M+49.0%$25.2M+198.2%$8.5M
Long-Term DebtN/AN/AN/AN/AN/AN/A$49.7M+7.8%$46.1M-34.9%$70.8M-16.8%$85.2M-6.9%$91.5M+2.1%$89.6M+2.2%$87.7M+3.0%$85.2M+11045.7%$764K
Total Equity$459.3M-5.5%$486.2M-11.9%$552.1M-7.3%$595.3M-10.8%$667.1M+6.3%$627.5M+3.2%$608.3M+299.3%$152.3M+334.0%-$65.1M-618.7%-$9.1M+93.0%-$129.2M-46.1%-$88.4M-161.2%-$33.9M-747.0%-$4.0M+33.0%-$6.0M
Retained Earnings-$1.7B-2.3%-$1.7B-5.2%-$1.6B-3.9%-$1.5B-7.4%-$1.4B+0.5%-$1.4B-1.3%-$1.4B-1.6%-$1.4B-9.2%-$1.3B-5.6%-$1.2B-7.7%-$1.1B-15.2%-$970.2M-6.2%-$913.9M-22.2%-$747.6M-31.5%-$568.5M

Not reported in any period shown, so not listed: Goodwill.

AMRN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AMRN annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$15.6M$6.7M+121.7%-$31.0M-550.9%$6.9M+103.8%-$180.1M-170.7%-$66.5M-206.0%-$21.7M-132.2%-$9.4M+90.1%-$94.7M-188.4%-$32.8M+54.3%-$71.8M+14.5%-$84.0M-12.6%-$74.6M+60.8%-$190.3M-55.6%-$122.3M-210.1%-$39.4M
Capital ExpendituresN/AN/AN/AN/AN/AN/A$252K-89.8%$2.5M+4172.4%$58K+383.3%$12K-42.9%$21K-25.0%$28KN/A$14K-97.4%$549K+37.9%$398K
Free Cash FlowN/AN/AN/AN/AN/AN/A-$22.0M-85.7%-$11.8M+87.5%-$94.8M-188.5%-$32.8M+54.3%-$71.8M+14.5%-$84.0MN/A-$190.3M-54.9%-$122.9M-208.4%-$39.8M
Investing Cash Flow-$17.8M$8.8M+119.2%-$46.0M-80.1%-$25.5M-114.6%$175.3M+68.4%$104.1M+127.6%-$377.0M-15112.4%-$2.5M-4172.4%-$58K-383.3%-$12K+42.9%-$21KN/AN/A-$14K+99.9%-$14.3M-600.3%-$2.0M
Financing Cash Flow-$2.2M-$2.0M-41.0%-$1.4M-727.4%$230K+160.7%-$379K+92.5%-$5.1M+91.4%-$58.9M-114.4%$409.6M+51.0%$271.3M+3193.9%$8.2M-87.0%$63.1MN/AN/A$121.6M-56.6%$280.3M+121.3%$126.6M
Share BuybacksN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$194KN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

AMRN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

AMRN annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin56.6%+21.0pp35.6%-18.3pp53.9%-11.7pp65.7%-13.5pp79.2%+0.6pp78.6%+0.9pp77.7%+1.5pp76.2%+1.0pp75.2%+1.6pp73.6%+7.7pp65.9%+3.7pp62.2%+7.4pp54.8%N/AN/A
Operating Margin-23.5%+16.7pp-40.2%-18.1pp-22.0%+6.7pp-28.7%-30.5pp1.8%+5.0pp-3.2%+2.5pp-5.7%+41.6pp-47.2%-22.1pp-25.1%+25.3pp-50.4%-120.1%-177.0%-691.1%N/AN/A
Net Margin-18.2%+19.9pp-38.1%-20.1pp-17.9%+10.7pp-28.7%-30.0pp1.3%+4.3pp-2.9%+2.3pp-5.3%+45.5pp-50.8%-13.3pp-37.5%+28.9pp-66.4%-140.9%-104.0%-630.8%N/AN/A
Return on Equity-8.5%+9.4pp-17.9%-7.9pp-10.0%+7.8pp-17.8%-18.9pp1.1%+4.0pp-2.9%+0.8pp-3.7%+72.7pp-76.4%N/AN/AN/AN/AN/AN/AN/A
Return on Assets-5.8%+6.9pp-12.7%-6.1pp-6.6%+5.3pp-11.9%-12.7pp0.7%+2.6pp-1.9%+0.7pp-2.6%+27.6pp-30.2%+11.8pp-42.0%+9.7pp-51.7%+14.8pp-66.5%-33.6pp-32.9%+32.9pp-65.8%-8.2pp-57.6%-2.9pp-54.7%
Current Ratio3.340.0x3.31+0.5x2.80+0.1x2.66+0.3x2.37-0.5x2.86-0.7x3.53+1.1x2.40+1.0x1.41-0.5x1.92-0.9x2.83-0.8x3.60-2.2x5.84-5.5x11.34-2.7x14.08
Debt-to-Equity0.46+0.1x0.41-0.1x0.510.0x0.49-0.1x0.60+0.1x0.54+0.5x0.08-0.2x0.30N/AN/AN/AN/AN/AN/AN/A
FCF MarginN/AN/AN/AN/AN/A-3.6%-0.8pp-2.8%+38.6pp-41.3%-23.2pp-18.1%+37.1pp-55.2%-102.8%N/A-722.4%N/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Amarin's annual revenue?

Amarin (AMRN) reported $213.6M in total revenue for fiscal year 2025. This represents a -6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Amarin's revenue growing?

Amarin (AMRN) revenue declined by 6.5% year-over-year, from $228.6M to $213.6M in fiscal year 2025.

Is Amarin profitable?

No, Amarin (AMRN) reported a net income of -$38.8M in fiscal year 2025, with a net profit margin of -18.2%.

Amarin (AMRN) reported diluted earnings per share of -$0.09 for fiscal year 2025. This represents a 55.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amarin (AMRN) had a gross margin of 56.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Amarin (AMRN) had an operating margin of -23.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Amarin (AMRN) had a net profit margin of -18.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Amarin (AMRN) has a return on equity of -8.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Amarin (AMRN) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Amarin (AMRN) had $670.8M in total assets as of fiscal year 2025, including both current and long-term assets.

Amarin (AMRN) invested $19.8M in research and development during fiscal year 2025.

Amarin (AMRN) had 416M shares outstanding as of fiscal year 2025.

Amarin (AMRN) had a current ratio of 3.34 as of fiscal year 2025, which is generally considered healthy.

Amarin (AMRN) had a debt-to-equity ratio of 0.46 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Amarin (AMRN) had a return on assets of -5.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Amarin (AMRN) has an Altman Z-Score of -1.85, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Amarin (AMRN) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Amarin (AMRN) reported a net loss of $38.8M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Amarin (AMRN) reported an operating loss of $50.2M against $7K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Amarin (AMRN) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top